Notice of Investment in EXORPHIA
Keio Innovation Initiative (KII) has invested in EXORPHIA, a pioneer in exosome drug discovery, which is attracting increasing attention as a next-generation drug, from a fund managed by KII.
For more details, please see the press release.
https://prtimes.jp/main/html/rd/p/000000028.000018580.html